Nervous System Diseases: Clinical Trials

276 trials for Nervous System Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

276 recruiting. 276 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4276Recruiting 276

Follow Nervous System Diseases: new trials by email Literature Review of Nervous System Diseases trials Research Report on Nervous System Diseases

Trials (filtered) newest first · largest first

All 276 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Safety and Effectiveness of ELEVIDYS in Participants With Duchenne Muscular Dystrophy Treated in a Post-Marketing Setting
ELEVIDYS, Sirolimus, Glucocorticoids - Duchenne Muscular Dystrophy
Phase 4RecruitingSarepta Therapeutics, Inc.202026-10-302026-10-06
Low-Volume Pericapsular Nerve Group (PENG) Block With Dexamethasone vs Standard-Volume PENG Block After Total Hip Arthroplasty
Pericapsular nerve group (PENG) block, Bupivacaine, Dexamethasone - Pain, Postoperative, Muscle Weakness
Phase 4RecruitingAin Shams University602026-10-152026-10-16
Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment
Trazodone + positive airway pressure (PAP) therapy, Oxygen + positive airway pressure (PAP) therapy - Sleep Disordered Breathing, Able Bodied
Phase 4RecruitingVA Office of Research and Development2002026-09-162026-10-13
NeuroAiD Patient-Reported Outcomes in Patients With Mild to Moderate Ischemic Stroke
MLC901, Standard treatment for acute ischemic stroke - Stroke, Stroke, Acute Ischemic
Phase 4RecruitingEVD Pharmacy and Medical Company Limited802026-09-102026-10-20
A Comparative Effectiveness Study of Positive Airway Pressure (PAP) Therapy, Dental Device, and Atomoxetine-Oxybutynin for Treatment of Obstructive Sleep Apnea in Adults
Positive airway pressure (PAP) therapy, Sleep dental device, Atomoxetine-oxybutynin - Obstructive Sleep Apnea (OSA)
Phase 4RecruitingSairam Parthasarathy24002026-09-042026-10-19
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
OCR SC - Multiple Sclerosis
Phase 4RecruitingGenentech, Inc.1002026-09-022026-10-30
Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients
Lemborexant, Placebo - Sleep Disturbance, Delirium
Phase 4RecruitingMahidol University1002026-09-012026-10-08
Comparing the Efficacy of Propofol and Dexmedetomidine in Prevention of Emergence Agitation After Sevoflurane Anesthesia in Children
propofol 1mg/kg, Dexmedetomidine - Emergence Delirium, Anesthesia
Phase 4RecruitingPakistan Institute of Medical Sciences1142026-08-282026-09-02
ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)
Onasemnogene Abeparvovec-brve - Spinal Muscular Atrophy
Phase 4RecruitingNovartis Pharmaceuticals362026-08-272026-10-29
Tirzepatide in Idiopathic Intracranial Hypertension Trial
Tirzepatide, Tirzepatide Placebo - Idiopathic Intracranial Hypertension (IIH)
Phase 4RecruitingDuke University602026-08-252026-09-15
Outcomes After Planned Discontinuation of AntiSeizure Medication
Discontinue antiseizure medications - Epilepsy
Phase 4RecruitingUniversity of Michigan402026-08-012026-08-06
Dexmedetomidine Versus Dexamethasone as Adjuvants to Bupivacaine for Intermediate Cervical Plexus Block
Dexmedetomidine Hydrochloride, Dexamethasone Phosphate - Analgesia
Phase 4RecruitingDamanhour Teaching Hospital602026-08-012026-09-21
Autonomic and Renal Contributions to Hypertension With ADT
Gonadotropin Releasing Hormone Agonists (GNRH), Androgen receptor (AR) inhibitor, Placebo - Androgen Deprivation Therapy, Prostate Cancer
Phase 4RecruitingVirginia Commonwealth University602026-08-012026-11-02
Success Rates and Safety of Steroid Injections in Managing Spinal and Sacro-Iliac Pain (CORTisone Injection Spine Study)
triamcinolone acetonide (Kenalog), Celestone Soluspan 6Mg/Ml Suspension for Injection, Depo-Medrol 40Mg/Ml Suspension for Injection - Back Pain Lower Back, Neck Pain
Phase 4RecruitingIgor Wilderman. MD5002026-07-302026-08-13
A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India
Rimegepant 75 mg ODT - Acute Treatment of Migraine
Phase 4RecruitingPfizer602026-07-242026-10-15
BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis
Apixaban, Clopidogrel - Stroke, Ischemic
Phase 4RecruitingYonsei University5862026-07-142026-10-16
Evaluation System for Lecanemab Efficacy Using Gold Electrode ECL to Monitor Alzheimer's Biomarkers
Lecanemab - Alzheimer Disease
Phase 4RecruitingThe Fourth Affiliated Hospital of Zhejiang University School of Medicine1002026-07-102026-07-07
Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
Acoramidis (AG10) oral tablet - Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM), Amyloidosis
Phase 4RecruitingEidos Therapeutics, a BridgeBio company1502026-07-012026-07-29
The Effects of Orexin Antagonism on Fear Extinction in PTSD
Suvorexant, Placebo - Insomnia, PTSD
Phase 4RecruitingVA Office of Research and Development401202026-07-012026-11-05
Propofol-Only Versus Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging
Dexmedetomidine (IV) 0.5 mcg/kg, Propofol (IV) 2-4 mg/kg, Dexmedetomidine (IV) 1 mcg/kg - MRI Sedation, Pediatric Sedation
Phase 4RecruitingBoston Children's Hospital1052026-06-302026-09-21

Showing 20 of 276. Sign in to see all of them.

Narrower conditions

Stroke (27)  ·  Agnosia (25)  ·  Ischemic Stroke (22)  ·  Emergence Delirium (12)  ·  Pain, Postoperative (12)  ·  Sleep Initiation and Maintenance Disorders (12)  ·  Atrial Fibrillation (11)  ·  Migraine Disorders (11)  ·  Alzheimer Disease (10)  ·  Parkinson Disease (9)  ·  Sleep Apnea Syndromes (8)  ·  Brain Injuries, Traumatic (7)  ·  Multiple Sclerosis (7)  ·  Pain (7)  ·  Sleep Apnea, Obstructive (7)

Broader conditions

Central Nervous System Diseases (146)  ·  Brain Diseases (136)  ·  Pathological Conditions, Signs and Symptoms (136)  ·  Signs and Symptoms (98)  ·  Neurologic Manifestations (95)  ·  Cardiovascular Diseases (71)  ·  Vascular Diseases (69)  ·  Pathologic Processes (63)  ·  Cerebrovascular Disorders (61)  ·  Mental Disorders (61)  ·  Neurobehavioral Manifestations (53)  ·  Sleep Wake Disorders (34)  ·  Neurocognitive Disorders (33)  ·  Dyssomnias (31)

Interventions

Saline Solution (11)  ·  Dexmedetomidine (10)  ·  Sodium Chloride (7)  ·  Bupivacaine (6)  ·  Dexamethasone (6)  ·  Lidocaine (6)  ·  Propofol (6)  ·  Rivaroxaban (6)  ·  Tablets (6)  ·  apixaban (6)  ·  Aspirin (5)  ·  Ketamine (5)  ·  Acetaminophen (4)  ·  Methylphenidate (4)  ·  Methylprednisolone (4)

Sponsors

VA Office of Research and Development (8)  ·  Mayo Clinic (6)  ·  Brigham and Women's Hospital (4)  ·  Duke University (4)  ·  Vanderbilt University Medical Center (4)  ·  Insel Gruppe AG, University Hospital Bern (3)  ·  Montefiore Medical Center (3)  ·  Weill Medical College of Cornell University (3)  ·  Xuanwu Hospital, Beijing (3)  ·  Yonsei University (3)  ·  Ain Shams University (2)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Beijing Tiantan Hospital (2)  ·  Centre Hospitalier Universitaire de Nice (2)  ·  Chinese Academy of Medical Sciences, Fuwai Hospital (2)

Countries

United States (118)  ·  China (50)  ·  Canada (12)  ·  Egypt (11)  ·  South Korea (9)  ·  Denmark (8)  ·  France (8)  ·  India (8)  ·  Russia (6)  ·  Spain (6)  ·  Brazil (5)  ·  Italy (5)  ·  Switzerland (5)  ·  Belgium (4)  ·  Germany (4)

Top investigators

Andrew D Krystal, MD, MS (2)  ·  Jana Ivanidze, MD/PhD (2)  ·  M Safwan Badr, MD (2)  ·  Xiangbin Pan, MD,PhD (2)  ·  Aaron M Cook, PharmD (1)  ·  Abeer Salamah, Lecturer (1)  ·  Ahmed Elhaddad, Ass.prof. (1)  ·  Ahmed M Shaat, MD (1)  ·  Alexa N Bramall, MD (1)  ·  Alister Bates, PhD (1)  ·  Amy Paller, MD (1)  ·  Andrew Little, MD (1)

Results publications

PMID 21869730, PMID 22230384, PMID 22880024, PMID 22897803, PMID 25771069, PMID 27834686, PMID 29030456, PMID 41616808, PMID 10634801, PMID 10770777, PMID 11018337, PMID 11498461, PMID 11587154, PMID 11737181, PMID 11914403, PMID 12221155, PMID 12748199, PMID 12807523, PMID 14690106, PMID 16436742, PMID 16731270, PMID 17496462, PMID 17548554, PMID 17548555, PMID 17920917, PMID 18292756, PMID 18467932, PMID 18499604, PMID 19020142, PMID 19054820, PMID 19151617, PMID 19171788, PMID 19225527, PMID 19573663, PMID 19724732, PMID 20581790, PMID 20740215, PMID 20854139, PMID 21079049, PMID 21179973, PMID 21623982, PMID 21734685, PMID 21739090, PMID 21899409, PMID 22232986, PMID 22472556, PMID 23039824, PMID 23045170, PMID 24036842, PMID 24462073

NIH funding

2025 (5), 2023 (4), 2018 (3), 2019 (1), I01CX001944 (1), I01CX002734 (1), I01RD001576 (1), K01HL164978 (1), K23AG081463 (1), K23DA057387 (1), P30CA033572 (1), P50NS123103 (1), R01AG051588 (1), R01AG093767 (1), R01DC012519 (1)